EN
HI
Summary
As of 29 Oct, 2026, Alivus Life Sciences stock price is ₹1406.1. During the trading session, the stock has moved between an intraday low of ₹1390.80 and an intraday high of ₹1437.40. Over the last 52 weeks, Alivus Life Sciences has traded between ₹819.00 and ₹1493.80.
The stock has recorded a trading volume of 1,15,484 shares,. Its Average Traded Price (ATP) is ₹1411.37, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1406.10.
Alivus Life Sciences has an upper circuit limit of ₹1679.20 and a lower circuit limit of ₹1119.60. The total value traded stands at ₹16.30 CR, and the delivery percentage for the day is 56.92%.
The stock is currently traded with a market lot size of 1. Alivus Life Sciences also offers a dividend yield of 0%.
Alivus Life Sciences Share Price Chart
Alivus Life Sciences Share Key Metrics
Volume
1.15 L
Market Cap
17180.64 CR
LTQ@LTP
5@1406.10
ATP
1411.37
Var Margin
16.75 %
Circuit Range
1119.6-1679.2
Delivery %
56.92 %
Value
16.30 CR
ASM/GSM
No
Market Lot
1
Alivus Life Sciences Resistance and Support
Pivot 1378.3
Resistance
First Resistance
1426.2
Second Resistance
1453
Third Resistance
1500.9
Support
First Support
1351.5
Second Support
1303.6
Third Support
1276.8
Alivus Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 29 2026 | 1400 | 1406.1 | 0.48% | 1437.4 | 1390.8 |
| Wed Oct 28 2026 | 1343.59 | 1399.4 | 4.15% | 1405.09 | 1330.4 |
| Tue Oct 27 2026 | 1256 | 1343.59 | 6.47% | 1357.8 | 1256 |
Alivus Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-30 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-01-22 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-15 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
Alivus Life Sciences News
Alivus Life Sciences Ltd - 543322 - Closure of Trading Window
Alivus Life Sciences has scheduled a board meeting on October 29, 2026. The board will consider and approve the financial results for Q2 FY27.
Oct 21 2026 17:17:01
Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for Inter-Alia, Considering And Approving Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026.
Alivus Life Sciences' board will meet on October 29, 2026, for financial results. The results will cover the quarter and half-year ended September 30, 2026.
Oct 21 2026 17:09:13
Alivus Life Sciences Management
| Name | Position |
|---|---|
| Rudalf Corriea | Company Secretary & Compliance Officer |
| Hiren K Patel | Chairman |
Alivus Life Sciences Similar Stocks
Vijaya Diagnostic Centre Ltd.
1436.20
-6.60 (0.46%)
Molbio Diagnostics Ltd.
1294.00
-18.70 (1.42%)
Concord Biotech Ltd.
1237.60
-30.90 (2.44%)
Marksans Pharma Ltd.
312.65
7.45 (2.44%)
CORONA Remedies Ltd.
2174.30
-26.30 (1.20%)
Rainbow Children's Medicare Ltd.
1205.00
0.20 (0.02%)
Sudeep Pharma Ltd.
1123.70
4.70 (0.42%)
Metropolis Healthcare Ltd.
548.90
-2.30 (0.42%)
Sanofi Consumer Healthcare India Ltd.
3510.10
187.30 (5.64%)
Akums Drugs & Pharmaceuticals Ltd.
729.00
6.30 (0.87%)
Alivus Life Sciences FAQs
The Buying Price of Alivus Life Sciences share is 1406.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alivus Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alivus Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alivus Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alivus Life Sciences shares is 0. Useful to assess the stock's value relative to its book value.
To assess Alivus Life Sciences’s valuation compare Sector P/E, P/B which are 39.87 & 3.27 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alivus Life Sciences is 17180.64 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alivus Life Sciences share price is 1493.80 & 819.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alivus Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ALIVUS
